IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I. Luttichuys who wrote (1319)	10/22/1997 9:28:00 PM
From: Brad C. Dunlap	Read Replies (3) of 1762

Hi Bennett, just a few comments of interest. The cure for lymphoma foundation's [CFL] November 17th newsletter had a nice report on C2B8[rituxan] featured on the front page. The following is a quote from Wendy S. Harpham, M.D. " After living with this disease for seven years, through seven various courses of treatment, here is what C2B8[rituxan] means to me... The availability of this treatment tames my greatest fear- not living to raise my children... It is very possible that C2B8 alone can keep me alive with a good quality of life for many, many years... C2B8 allowed me to avoid the acute and long term toxicities of chemotherapy...[it] has not eliminated any standard treatment options for me should the C2B8 no longer be effective against my lymphoma at some time in the future." I also understand that Idec was mentioned in the latest Fortune magazine as the next potential blockbuster biotechnology company to watch. I have not actually seen the article but read a short blurb summarizing the article. As always, I enjoy your comments and posts.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next